Friday, 27 November 2020

FDA Approves Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the Treatment of Neuroblastoma



source https://www.pharmatutor.org/pharma-news/2020/fda-approves-y-mabs-danyelza-naxitamab-gqgk-for-the-treatment-of-neuroblastoma

No comments:

Post a Comment

Pharmaceutical jobs for MPharm / MSc / BPharm or BSc - DPharm or PharmD and PhD

  Openings for Pharmacists under the National Health Mission Degree or Diploma in Pharmacy (50%) & Registration in CG Pharmacy Registrat...